New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.

Hypertension 2014 Feb 28;63(2):346-52. Epub 2013 Oct 28.

Department of Obstetrics, Charité University Medicine Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

To establish gestational phase adapted cutoffs for the use of the soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio as a diagnostic tool for preeclampsia in the clinical setting, a multicenter case-control study including a total of 1149 patients was performed. We report normal values of sFlt-1, PlGF, and the sFlt-1/PlGF ratio based on the analysis of a total of 877 patients with uneventful pregnancy outcome. A total of 234 patients with preeclampsia and a matched cohort consisting of 468 patients with normal pregnancy outcome were compared, and sFlt-1 and PlGF were measured on an automated platform. Separate cutoffs for the sFlt-1/PlGF ratio were determined for the early (20+0-33+6 weeks) and the late gestational phase (34+0 weeks-delivery). For each of the 2 gestational phases, 2 independent cutoffs framing an equivocal zone were determined: the first cutoff with focus on high sensitivity, and the second focusing on high specificity. Between 20+0 and 33+6 weeks, the cutoffs at ≤33 and ≥85 resulted in a sensitivity/specificity of 95%/94% and 88%/99.5%, respectively. An sFlt-1/PlGF ratio of ≤33 had the lowest likelihood of a negative test (0.05; 95% confidence interval, 0.02-0.13), whereas values ≥85 had the highest likelihood of a positive test (176; 95% confidence interval, 24.88-1245). After 34+0 weeks, the cutoffs at ≤33 and ≥110 yielded a sensitivity/specificity of 89.6%/73.1% and 58.2%/95.5%, respectively. The approach to use multiple cutoffs for the early and late gestational phase enhances the diagnostic accuracy of the sFlt-1/PlGF ratio as a diagnostic tool for preeclampsia.

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.01787DOI Listing
February 2014
4 Reads

Publication Analysis

Top Keywords

sflt-1/plgf ratio
16
ratio diagnostic
12
gestational phase
12
weeks cutoffs
8
95% confidence
8
growth factor
8
sflt-1 plgf
8
fms-like tyrosine
8
confidence interval
8
cutoffs ≤33
8
late gestational
8
tool preeclampsia
8
pregnancy outcome
8
diagnostic tool
8
soluble fms-like
8
cutoffs
6
ratio
6
gestational
5
platform separate
4
phase 34+0
4

References

(Supplied by CrossRef)

Similar Publications